Multidrug-Resistant Mycobacterium Tuberculosis in a Community Hospital, Luanda, Angola
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
In a longitudinal study in a first-level hospital in Luanda, Angola, we found rifampin-resistant and multidrug-resistant tuberculosis (TB) in 38 (8%, 95% CI 5.7-10.8) of 474 patients with no previous history of TB. Of note, 2 patients (0.4%, 95% CI 0.1-1.5) demonstrated pre-extensively drug-resistant TB.
References
1.
Perdigao J, Clemente S, Ramos J, Masakidi P, Machado D, Silva C
. Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in Angola. Sci Rep. 2017; 7:42814.
PMC: 5322374.
DOI: 10.1038/srep42814.
View
2.
Aznar M, Rando-Segura A, Moreno M, Soley M, Igual E, Bocanegra C
. Prevalence and risk factors of multidrug-resistant tuberculosis in Cubal, Angola: a prospective cohort study. Int J Tuberc Lung Dis. 2019; 23(1):67-72.
DOI: 10.5588/ijtld.18.0231.
View
3.
Sebastiao C, Samulengo J, Sacomboio E, Francisco N, Teixeira C, Antonio S
. Epidemiological Characteristics and Risk Factors Related to Drug-resistant Tuberculosis in Luanda, Angola. Am J Trop Med Hyg. 2022; 106(3):779-784.
PMC: 8922512.
DOI: 10.4269/ajtmh.21-0659.
View
4.
Robbiati C, Tosti M, Mezzabotta G, Dal Maso F, Lulua Sachicola O, Siene Tienabe P
. Improving TB Surveillance and Patients' Quality of Care Through Improved Data Collection in Angola: Development of an Electronic Medical Record System in Two Health Facilities of Luanda. Front Public Health. 2022; 10:745928.
PMC: 9009439.
DOI: 10.3389/fpubh.2022.745928.
View